Search Results - "MOMOSE, Kazuhiro"

Refine Results
  1. 1
  2. 2

    Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species by Matsumoto, Mitsuyuki, Nomura, Tamako, Momose, Kazuhiro, Ikeda, Yasushi, Kondou, Yutaka, Akiho, Hiraku, Togami, Junji, Kimura, Yasuharu, Okada, Masamichi, Yamaguchi, Tokio

    Published in The Journal of biological chemistry (01-11-1996)
    “…Neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) belong to a family of structurally related peptides which have numerous functions in…”
    Get full text
    Journal Article
  3. 3

    Endomorphins have orexigenic and anxiolytic activities in mice by Asakawa, Akihiro, Inui, Akio, Momose, Kazuhiro, Ueno, Naohiko, Fujino, Masayuki A, Kasuga, Masato

    Published in Neuroreport (13-07-1998)
    “…THIS study was designed to investigate the effects of endomorphin 1 and 2, recently identified μ-opioid receptor selective peptides, on food intake and anxiety…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Both V 1A and V 1B vasopressin receptors deficiency result in impaired glucose tolerance by Nakamura, Kazuaki, Aoyagi, Toshinori, Hiroyama, Masami, Kusakawa, Shinji, Mizutani, Reiko, Sanbe, Atsushi, Yamauchi, Junji, Kamohara, Masazumi, Momose, Kazuhiro, Tanoue, Akito

    Published in European journal of pharmacology (24-06-2009)
    “…[Arg 8]-vasopressin (AVP) is involved in the regulation of glucose homeostasis via vasopressin V 1A and vasopressin V 1B receptor. Our previous studies have…”
    Get full text
    Journal Article
  6. 6

    Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a by ONDA, Kenichi, SUZUKI, Takayuki, TSUKAMOTO, Shin-Ichi, SHIRAKI, Ryota, YONETOKU, Yasuhiro, NEGORO, Kenji, MOMOSE, Kazuhiro, KATAYAMA, Naoko, ORITA, Masaya, YAMAGUCHI, Tomohiko, OHTA, Mitsuaki

    Published in Bioorganic & medicinal chemistry (15-05-2008)
    “…A series of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives were prepared and evaluated as inhibitors of human liver glycogen phosphorylase a (hLGPa). One…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors by Onda, Kenichi, Shiraki, Ryota, Yonetoku, Yasuhiro, Momose, Kazuhiro, Katayama, Naoko, Orita, Masaya, Yamaguchi, Tomohiko, Ohta, Mitsuaki, Tsukamoto, Shin-ichi

    Published in Bioorganic & medicinal chemistry (15-09-2008)
    “…(2 E,2′ E)- N, N′-Pentane-1,5-diylbis[3-(3,4-dichlorophenyl)acrylamide] and its heteroatom-containing analogues are potent inhibitors of human liver glycogen…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Effects of YM218, a nonpeptide vasopressin V 1A receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells by Tahara, Atsuo, Tsukada, Junko, Tomura, Yuichi, Momose, Kazuhiro, Suzuki, Takeshi, Yatsu, Takeyuki, Shibasaki, Masayuki

    Published in European journal of pharmacology (24-05-2006)
    “…Mesangial cells are centrally-located glomerular pericytes with contractile, endocrine, and immunity-regulating functions. These cells are thought to maintain…”
    Get full text
    Journal Article
  13. 13

    Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells by Tahara, Atsuo, Tsukada, Junko, Tomura, Yuichi, Momose, Kazuhiro, Suzuki, Takeshi, Yatsu, Takeyuki, Shibasaki, Masayuki

    Published in European journal of pharmacology (24-05-2006)
    “…Mesangial cells are centrally-located glomerular pericytes with contractile, endocrine, and immunity-regulating functions. These cells are thought to maintain…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Neuropeptide Y Produces Anxiety Via Y2-Type Receptors by Nakajima, Masaharu, Inui, Akio, Asakawa, Akihiro, Momose, Kazuhiro, Ueno, Naohiko, Teranishi, Arata, Baba, Shigeaki, Kasuga, Masato

    Published in Peptides (New York, N.Y. : 1980) (01-01-1998)
    “…Nakajima, M., A. Inui, A. Asakawa, K. Momose, N. Ueno, A. Teranishi, S. Baba and M. Kasuga. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides…”
    Get full text
    Journal Article
  18. 18

    Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats by Kurosaki, Eiji, Nakano, Ryosuke, Momose, Kazuhiro, Shimaya, Akiyoshi, Suzuki, Takayuki, Shibasaki, Masayuki, Shikama, Hisataka

    Published in European journal of pharmacology (09-05-2003)
    “…Using a glucose clamp, we had shown that YM440, ( Z)-1,4-bis{4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}but-2-ene, reduced the increased hepatic…”
    Get full text
    Journal Article
  19. 19

    Binding and signal transduction characteristics of the nonpeptide vasopressin V1A receptor-selective antagonist YM218 in cultured rat mesangial cells by Tahara, Atsuo, Tsukada, Junko, Tomura, Yuichi, Kusayama, Toshiyuki, Momose, Kazuhiro, Taniguchi, Nobuaki, Suzuki, Takeshi, Yatsu, Takeyuki, Shibasaki, Masayuki

    Published in Pharmacology (2006)
    “…Vasopressin (AVP) causes mesangial cell contraction, proliferation and hypertrophy. The present study investigated the effects of YM218, a potent, nonpeptide…”
    Get more information
    Journal Article
  20. 20